TY  - GEN
AU  - Moreau,Philippe
AU  - Mateos,Maria-Victoria
AU  - Berenson,James R
AU  - Weisel,Katja
AU  - Lazzaro,Antonio
AU  - Song,Kevin
AU  - Dimopoulos,Meletios A
AU  - Huang,Mei
AU  - Zahlten-Kumeli,Anita
AU  - Stewart,A Keith
TI  - Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
SN  - 1474-5488
PY  - 2019///0408
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Dexamethasone
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Lenalidomide
KW  - Male
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Oligopeptides
KW  - Prognosis
KW  - Proteasome Inhibitors
KW  - Recurrence
KW  - Risk Assessment
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(18)30354-1
ER  -